Search results
ASCO24: Enhertu aims to replace Herceptin in first-line metastatic breast cancer
Pharmaceutical Technology via Yahoo Finance· 5 days agoInterim safety and efficacy results of the Phase Ib/II Destiny-BREAST07 trial with Enhertu...
These 2 ‘Strong Buy’ Penny Stocks Are Poised for a Massive Rally, Say Analysts
TipRanks via Yahoo Finance· 2 days agoThere are two sides to every coin. This holds particularly true for penny stocks, or tickers that...
Gilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of...
Morningstar· 6 days agoGilead and Arcus Announce EtrumadenantPlus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal Cancer – In Cohort B of the ARC-9 mCRC Study, Etrumadenant ...
Celularity reports advances in cancer T-cell therapy By Investing.com
Investing.com· 4 days agoCelularity Inc. (NASDAQ: CELU), a biotechnology firm specializing in regenerative medicine,...
Fauci Grilled by Lawmakers on Masks, Vaccine Mandates and Lab Leak Theory
New York Times· 5 days agoDr. Fauci testified before a House panel investigating Covid’s origins. Dr. Anthony S. Fauci, the...
AbbVie treats first subject in Phase III multiple myeloma drug trial
Clinical Trials Arena via Yahoo Finance· 2 days agoAbbVie has treated the first subject in the Phase III CERVINO clinical trial of its investigational...
Phase 2 Study Shows Opdivo-Yervoy Highly Effective In Colon Cancer
Forbes· 21 hours agoA four-week course of dual immunotherapy prior to surgery is highly effective in treating a certain...
mRESVIA’s FDA approval paves the way for mRNA vaccines across multiple indications
Clinical Trials Arena via Yahoo Finance· 2 days agoModerna’s respiratory syncytial virus (RSV) vaccine mRESVIA has received US Food and Drug...
Bio-Sourcing and Afrigen Biologics partner on biomanufacturing platform
Medical Device Network via Yahoo Finance· 3 days agoBelgian biotech, Bio-Sourcing, and Cape Town based company, Afrigen Biologics, have signed a...
Cancer Drugs: Deals and Licensing for Antibody-Drug Conjugates
The National Law Review· 2 days agoAntibody-drug conjugates (ADCs) are a promising class of cancer treatments with an accelerating...